These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 17431077)

  • 1. Pisa syndrome resolved after switching to olanzapine.
    Nishimura K; Mikami Y; Tsuchibuchi S; Horikawa N
    J Neuropsychiatry Clin Neurosci; 2007; 19(2):202-3. PubMed ID: 17431077
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia.
    Akerele E; Levin FR
    Am J Addict; 2007; 16(4):260-8. PubMed ID: 17661193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of switching from olanzapine to risperidone on the prevalence of the metabolic syndrome in overweight or obese patients with schizophrenia or schizoaffective disorder: analysis of a multicenter, rater-blinded, open-label study.
    Meyer JM; Pandina G; Bossie CA; Turkoz I; Greenspan A
    Clin Ther; 2005 Dec; 27(12):1930-41. PubMed ID: 16507379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
    J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pisa syndrome-like peculiar posture occurred while running was successfully improved with risperidone.
    Harada K; Saito T
    Psychiatry Clin Neurosci; 2006 Dec; 60(6):771-2. PubMed ID: 17109715
    [No Abstract]   [Full Text] [Related]  

  • 6. Schizophrenic patients treated with clozapine or olanzapine perform better on theory of mind tasks than those treated with risperidone or typical antipsychotic medications.
    Savina I; Beninger RJ
    Schizophr Res; 2007 Aug; 94(1-3):128-38. PubMed ID: 17560766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quality of life and social functioning in schizophrenic patients treated with olanzapine: 1 year follow-up naturalistic study].
    Mayoral F; Montejo AL; Bousoño M; González-Torres MA; Olivares JM; Ros S; Sanjuán J; Escobar R; Lara N
    Actas Esp Psiquiatr; 2006; 34(1):7-15. PubMed ID: 16525900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment persistence: a comparison among patients with schizophrenia who were initiated on atypical antipsychotic agents.
    Ren XS; Qian S; Lee AF; Herz L; Miller DR; Kazis LE
    J Clin Pharm Ther; 2006 Feb; 31(1):57-65. PubMed ID: 16476121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.
    Wang X; Savage R; Borisov A; Rosenberg J; Woolwine B; Tucker M; May R; Feldman J; Nemeroff CB; Miller AH
    J Psychiatr Res; 2006 Oct; 40(7):669-76. PubMed ID: 16762371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensive weight loss in a patient with schizophrenia after switching from olanzapine to aripiprazole. A case report.
    Luebbe G; Kropp S; Harms E; Ziegenbein M
    Pharmacopsychiatry; 2006 Mar; 39(2):76. PubMed ID: 16555168
    [No Abstract]   [Full Text] [Related]  

  • 11. Time to discontinuation and self-discontinuation of olanzapine and risperidone in patients with schizophrenia in a naturalistic outpatient setting.
    Kilzieh N; Todd-Stenberg JA; Kennedy A; Wood AE; Tapp AM
    J Clin Psychopharmacol; 2008 Feb; 28(1):74-7. PubMed ID: 18204345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching to risperidone after unsuccessful treatment of olanzapine in the first-episode schizophrenia: an open trial.
    Takahashi H; Yoshida K; Ishigooka J; Higuchi H
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1067-72. PubMed ID: 16759777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Olanzapine-associated neuroleptic malignant syndrome. A case report and favorable response to risperidone].
    López-Torres E; Cobo I; Lucena MI
    Actas Esp Psiquiatr; 2007; 35(2):145-6. PubMed ID: 17401786
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect on lipid profiles of switching from olanzapine to another second-generation antipsychotic agent in veterans with schizophrenia.
    Garman PM; Ried LD; Bengtson MA; Hsu C; McConkey JR
    J Am Pharm Assoc (2003); 2007; 47(3):373-8. PubMed ID: 17510032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are high initial doses of olanzapine required to reduce agitation associated with schizophrenia?
    Townsend MH; Baier MB
    J Clin Psychopharmacol; 2004 Feb; 24(1):95-7. PubMed ID: 14709956
    [No Abstract]   [Full Text] [Related]  

  • 16. A preliminary study of the comparative effects of olanzapine and risperidone on cognition in schizophrenia.
    Kim YT; Kang BJ
    Hum Psychopharmacol; 2004 Jun; 19(4):265-9. PubMed ID: 15181655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation of atypical antipsychotic agents and health outcomes in patients with schizophrenia.
    Ren XS; Lee AF; Huang YH; Hamed A; Herz L; Miller DR; Kazis LE
    J Clin Pharm Ther; 2004 Oct; 29(5):471-81. PubMed ID: 15482392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obsessive-compulsive symptoms in a randomized, double-blind study with olanzapine or risperidone in young patients with early psychosis.
    van Nimwegen L; de Haan L; van Beveren N; Laan W; van den Brink W; Linszen D
    J Clin Psychopharmacol; 2008 Apr; 28(2):214-8. PubMed ID: 18344733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia.
    Lang DJ; Kopala LC; Vandorpe RA; Rui Q; Smith GN; Goghari VM; Lapointe JS; Honer WG
    Am J Psychiatry; 2004 Oct; 161(10):1829-36. PubMed ID: 15465980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comments to the editor on "Outcomes and costs of risperidone versus olanzapine in patients with chronic schizophrenia or schizoaffective disorders: a Markov model".
    Clewell JD; Baker RW
    Value Health; 2005; 8(2):175-6. PubMed ID: 15804326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.